Matthias Keller

Title: Matthias Keller: Innovator in Medical Diagnostics

Introduction

Matthias Keller is a notable inventor based in Essen, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the areas of asphyxia and neonatal encephalopathy. With a total of 3 patents, Keller's work is focused on developing innovative methods for diagnosing and treating critical medical conditions.

Latest Patents

Keller's latest patents include a groundbreaking method of diagnosing and treating asphyxia. This method involves in vitro diagnostics to estimate the duration of hypoxia in patients and monitor various oxygen therapy conditions. It quantitatively detects specific endogenous compounds related to asphyxia, such as biogenic amines, amino acids, and lipids. Another significant patent addresses the diagnosis and treatment of neonatal encephalopathy. This invention utilizes metabolite signatures as biomarkers for early detection of brain injury and assessing the prognosis of affected brain areas.

Career Highlights

Throughout his career, Matthias Keller has worked with prominent companies in the biotechnology sector, including Infandx AG and Biocrates Life Sciences AG. His expertise in medical diagnostics has positioned him as a key figure in advancing healthcare technologies.

Collaborations

Keller has collaborated with esteemed professionals in his field, including David Enot and Hans-Peter Deigner. These partnerships have further enhanced his research and development efforts in medical diagnostics.

Conclusion

Matthias Keller's innovative contributions to medical diagnostics demonstrate his commitment to improving patient care through advanced technology. His patents reflect a deep understanding of critical health issues and a dedication to finding effective solutions.